Dow Rises on Global Economic Hopes as Merck, Pfizer Jump; Microsoft Falls

With the Fed out of the stimulus picture, investors now hope for favorable moves from foreign central banks. Find out why health-care stocks rose Wednesday.

Mar 26, 2014 at 11:00AM
Longview

The Dow Jones Industrials (DJINDICES:^DJI) this morning followed through on their gain from Tuesday, climbing 18 points as of 11 a.m. EDT. Favorable economic news on durable goods orders, which rose 2.2% in February, showed that the U.S. economy appears to be on solid footing, and internationally minded investors are starting to look at possible stimulus moves from China and the European Central Bank as potentially driving global stocks higher. Among Dow stocks, pharma giants Merck (NYSE:MRK) and Pfizer (NYSE:PFE) led the Dow higher, even as Microsoft (NASDAQ:MSFT) posted the biggest decline as of midmorning.

Merck climbed 2% after reports that the drugmaker will join GlaxoSmithKline (NYSE:GSK) in choosing to stop helping low-income Obamacare patients pay for their drugs. The move highlights the sensitivity that Obamacare has raised on the health-care front, as Merck has argued that by some readings such moves could constitute impermissible kickbacks under the federal law. According to Bloomberg, Pfizer hasn't yet said what it plans to do on the issue.

Pfizer 1.3% boost came after it reported positive results in its phase 3B trial of its genotropin drug candidate. The drug is designed to help those who were born small for their gestational age catch up in height by age 2. By showing a statistically significant gain in height, Pfizer is hopeful that the growth hormone could be approved for those suffering from conditions in which use of the drug would be warranted.

G
Source: Wikimedia Commons.

Yet both Merck and Pfizer are arguably also benefiting from investor uncertainty about the biotech sector. As high-growth biotech stocks have soared over the past year, Merck and Pfizer have largely been left behind. But with lucrative dividends and growth prospects of their own stemming from demographic trends and other favorable developments, both of the Big Pharma companies look attractive. Moreover, with moves such as Merck's attempt to sell off its over-the-counter health products unit, shareholders could be rewarded for their patience.

Finally, Microsoft fell 1.3%. With technical support for the company's aging Windows XP product ending, Microsoft hopes to encourage users to upgrade to more recent operating systems. Yet for now, the company is getting bad publicity from warnings that security threats on machines running XP could rise dramatically. Microsoft will have to work hard to make sure that consumers don't perceive that they're being forced to upgrade against their will, or else removing support could backfire for the company.

Everything you need to know about Obamacare
Pfizer and Merck have gotten affected by Obamacare, but so has your own health-care situation. In only minutes, you can learn the critical facts you need to know in a special free report called "Everything You Need to Know About Obamacare." This FREE guide contains the key information and money-making advice that every American must know. Please click here to access your free copy.

Dan Caplinger has no position in any stocks mentioned. The Motley Fool owns shares of Microsoft. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Money to your ears - A great FREE investing resource for you

The best way to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as “binge-worthy finance.”

Feb 1, 2016 at 5:03PM

Whether we're in the midst of earnings season or riding out the market's lulls, you want to know the best strategies for your money.

And you'll want to go beyond the hype of screaming TV personalities, fear-mongering ads, and "analysis" from people who might have your email address ... but no track record of success.

In short, you want a voice of reason you can count on.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich," rated The Motley Fool as the #1 place online to get smarter about investing.

And one of the easiest, most enjoyable, most valuable ways to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as "binge-worthy finance."

Whether you make it part of your daily commute or you save up and listen to a handful of episodes for your 50-mile bike rides or long soaks in a bubble bath (or both!), the podcasts make sense of your money.

And unlike so many who want to make the subjects of personal finance and investing complicated and scary, our podcasts are clear, insightful, and (yes, it's true) fun.

Our free suite of podcasts

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. The show is also heard weekly on dozens of radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable. Rule Breaker Investing and Answers are timeless, so it's worth going back to and listening from the very start; the other three are focused more on today's events, so listen to the most recent first.

All are available for free at www.fool.com/podcasts.

If you're looking for a friendly voice ... with great advice on how to make the most of your money ... from a business with a lengthy track record of success ... in clear, compelling language ... I encourage you to give a listen to our free podcasts.

Head to www.fool.com/podcasts, give them a spin, and you can subscribe there (at iTunes, Stitcher, or our other partners) if you want to receive them regularly.

It's money to your ears.

 


Compare Brokers